Summary of Study ST000137
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000122. The data can be accessed directly via it's Project DOI: 10.21228/M8T59G This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
Study ID | ST000137 |
Study Title | Metabolomics in sarcoidosis |
Study Type | observation |
Study Summary | Metabolites in sarcoidosis patients |
Institute | Wayne State University |
Department | Internal Medicine |
Last Name | Geamanu |
First Name | Andreea |
ageamanu@med.wayne.edu | |
Submit Date | 2015-02-11 |
Total Subjects | 30 |
Raw Data Available | No |
Analysis Type Detail | NMR |
Release Date | 2015-02-11 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR000122 |
Project DOI: | doi: 10.21228/M8T59G |
Project Title: | Metabolomics in Sarcoidosis |
Institute: | Wayne State University |
Department: | Internal Medicine |
Laboratory: | Samavati Lab |
Last Name: | Samavati |
First Name: | Lobelia |
Email: | lsamavat@med.wayne.edu |
Subject:
Subject ID: | SU000156 |
Subject Type: | Human |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Species Group: | Human |
Factors:
Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)
mb_sample_id | local_sample_id | Sample Group |
---|---|---|
SA007469 | C49 | Control |
SA007470 | C48 | Control |
SA007471 | C51 | Control |
SA007472 | C54 | Control |
SA007473 | C28 | Control |
SA007474 | C55 | Control |
SA007475 | C46 | Control |
SA007476 | C57 | Control |
SA007477 | C31 | Control |
SA007478 | C37 | Control |
SA007479 | C33 | Control |
SA007480 | C30 | Control |
SA007481 | C36 | Control |
SA007482 | C35 | Control |
SA007483 | C34 | Control |
SA007484 | P246 | Patient |
SA007485 | P233 | Patient |
SA007486 | P239 | Patient |
SA007487 | P248 | Patient |
SA007488 | P232 | Patient |
SA007489 | P250 | Patient |
SA007490 | P247 | Patient |
SA007491 | P197 | Patient |
SA007492 | P128 | Patient |
SA007493 | P112 | Patient |
SA007494 | P138 | Patient |
SA007495 | P217 | Patient |
SA007496 | P230 | Patient |
SA007497 | P218 | Patient |
SA007498 | P231 | Patient |
Showing results 1 to 30 of 30 |
Collection:
Collection ID: | CO000140 |
Collection Summary: | - |
Sample Type: | Serum |
Treatment:
Treatment ID: | TR000158 |
Treatment Summary: | None |
Sample Preparation:
Sampleprep ID: | SP000153 |
Sampleprep Summary: | Serum samples were analyzed following filtration through a 3-kD nominal cut-off membrane (Amicon Ultra 0.5 mL centrifugal filters, Millipore Corp, Billerica, MA) to remove proteins, lipids, lipoproteins, and protein-bound forms of certain molecules. Each serum sample was transferred to a prewashed filter and centrifuged at 13,800 g for 60 minutes as previously described (Gregory, Park et al. 2013). The filters were further washed with deuterium oxide (D2O) and the filtrate was mixed with the filtered serum in a 1:1 ratio. A reference buffer solution containing 5 mmol/L disodium-2,2-dimethyl 2-silapentane-5-sulphonate (DSS) and 10 mmol/L imidazole in D2O was added to the samples in a 1:9 ratio. The D2O provided a field-frequency lock, whereas DSS was used as the chemical shift reference and imidazole as pH indicator for the NMR spectra. A total of 600 µL mixture was transferred to a 5 mm NMR tube (Sigma Aldrich, St. Louis, MO). |
Analysis:
Analysis ID: | AN000219 |
Analysis Type: | NMR |
Chromatography ID: | CH000151 |
Num Factors: | 2 |
Num Metabolites: | 33 |
NMR:
NMR ID: | NM000051 |
Analysis ID: | AN000219 |
Instrument Name: | Agilent |
Instrument Type: | FT-NMR |
NMR Experiment Type: | NOESY |
Spectrometer Frequency: | 600 MHz |